The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health
Lipids in Health and Disease
Julius Oben (juliusoben@hotmail.com)
Ebangha Enonchong (juliusoben@hotmail.com)
Dieudonne Kuate (juliusoben@hotmail.com)
Dora Mbanya (juliusoben@hotmail.com)
Tiffany C Thomas (tiffany@heponline.com)
DeWall J Hildreth (dochildreth@cox.net)
Thomas D Ingolia (tingolia@heponline.com)
Michael S Tempesta (natprod@aol.com)
2007, 6:20 doi:10.1186/1476-511X-6-20ISSN
1476-511XArticle type
ResearchSubmission date
12 June 2007Acceptance date
5 September 2007Publication date
5 September 2007Article URL
This peer-reviewed article was published immediately upon acceptance. It can be downloaded, printed and distributed freely for any purposes (see copyright notice below).
Articles in
For information about publishing your research in
Lipids in Health and Disease are listed in PubMed and archived at PubMed Central.Lipids in Health and Disease or any BioMed Central journal, go toFor information about other BioMed Central publications go to
Lipids in Health and Disease
© 2007 Oben
This is an open access article distributed under the terms of the Creative Commons Attribution License (
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.et al., licensee BioMed Central Ltd.http://creativecommons.org/licenses/by/2.0),
Reading published clinical research by medical doctors should carry a lot of weight for those looking for healthy alternatives. Until this product can be isolated and synthesized by large companies, it will be more expensive that pills out of a jar, and much healthier as well.
ReplyDelete